Association between perfluorooctanoic acid exposure and degranulation of mast cells in allergic inflammation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Applied Toxicology

• Publication date

  2017-05-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1002/jat.3389PMID 27682001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory effect of 1,2,4,5-tetramethoxybenzene on mast cell-mediated allergic inflammation through suppression of IκB kinase complex.

  2015cited by this paper
• SG-HQ2 inhibits mast cell-mediated allergic inflammation through suppression of histamine release and pro-inflammatory cytokines

  2015cited by this paper
• Anti-inflammatory Effect of Alloferon on Ovalbumin-induced Asthma

  2015influential reference
• Does β-Hexosaminidase Function Only as a Degranulation Indicator in Mast Cells? The Primary Role of β-Hexosaminidase in Mast Cell Granules

  2014cited by this paper
• Calcio, canales, señalización intracelular y autoinmunidad

  2014cited by this paper
• Calcium, channels, intracellular signaling and autoimmunity.

  2014cited by this paper
• Curine inhibits mast cell-dependent responses in mice.

  2014cited by this paper
• Late-breaking abstract: A novel model of IgE-mediated passive pulmonary anaphylaxis in rats

  2014cited by this paper
• Licochalcone Suppresses LXRα-Induced Hepatic Lipogenic Gene Expression through AMPK/Sirt1 Pathway Activation

  2014cited by this paper
• Inhibitory effect of putranjivain A on allergic inflammation through suppression of mast cell activation.

  2014cited by this paper
• Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children

  2013cited by this paper
• Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis

  2013cited by this paper
• Galangin attenuates mast cell-mediated allergic inflammation.

  2013cited by this paper
• IgE and mast cells in allergic disease

  2012cited by this paper
• The role of mast cells in allergic inflammation.

  2012influential reference
• Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators.

  2012influential reference
• Mast cells and inflammation.

  2012cited by this paper
• Role of mast cells in innate and adaptive immunity.

  2012cited by this paper
• Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature.

  2012influential reference
• Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure.

  2011cited by this paper
• Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI.

  2011cited by this paper
• Increased susceptibility of 129SvEvBrd mice to IgE-Mast cell mediated anaphylaxis

  2011cited by this paper
• Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm

  2011cited by this paper
• Cytokine release from innate immune cells: association with diverse membrane trafficking pathways.

  2011cited by this paper
• Perfluorinated substances in human food and other sources of human exposure.

  2010influential reference
• Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis.

  2010cited by this paper
• IgG-mediated systemic anaphylaxis to protein antigen can be induced even under conditions of limited amounts of antibody and antigen.

  2010cited by this paper
• Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia

  2009cited by this paper
• The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha).

  2009influential reference
• The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell

  2009cited by this paper
• Perfluorinated compounds--exposure assessment for the general population in Western countries.

  2009cited by this paper
• The nuclear factor NF-kappaB pathway in inflammation.

  2009influential reference
• Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds.

  2008influential reference
• Opinion of the Scientific Panel on Contaminants in the Food chain on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts

  2008cited by this paper
• Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts Scientific Opinion of the Panel on Contaminants in the Food chain.

  2008cited by this paper
• Perfluorinated compounds: occurrence and risk profile.

  2008cited by this paper
• Estimating Consumer Exposure to PFOS and PFOA

  2008cited by this paper
• Effect of temperature control upon a mouse model of partial hepatic ischaemia/reperfusion injury

  2008cited by this paper
• New developments in FcεRI regulation, function and inhibition

  2007cited by this paper
• Perfluoroalkyl acids: a review of monitoring and toxicological findings.

  2007cited by this paper
• Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin.

  2007cited by this paper
• Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells.

  2006cited by this paper
• Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

  2006cited by this paper
• Molecular regulation of mast cell activation.

  2006cited by this paper
• Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

  2006cited by this paper
• Historical Comparison of Perfluorooctanesulfonate, Perfluorooctanoate, and Other Fluorochemicals in Human Blood

  2005cited by this paper
• FcɛRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane

  2005cited by this paper
• The Toxicology of Perfluorooctanoate

  2004cited by this paper
• Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

  2003cited by this paper
• Raising awareness of the rise in allergy-related conditions.

  2003cited by this paper
• Mast cells: beyond IgE.

  2003cited by this paper
• FcεRI Signaling of Mast Cells Activates Intracellular Production of Hydrogen Peroxide: Role in the Regulation of Calcium Signals 1

  2003cited by this paper
• Concentrations and spatial variations of polybrominated diphenyl ethers and several organochlorine compounds in fishes from the northeastern United States.

  2002cited by this paper
• Mast cells and inflammation.

  2002cited by this paper
• Perfluorochemical surfactants in the environment.

  2002cited by this paper
• Peer Reviewed: Perfluorochemical Surfactants in the Environment

  2002cited by this paper
• Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice.

  2000cited by this paper
• Rat basophilic leukaemia (RBL) cells overexpressing Rab3a have a reversible block in antigen-stimulated exocytosis.

  1997cited by this paper
• Enzymes of the mast cell granule.

  1980cited by this paper

• PFOS and PFOA exposure induces liver injury and sex-dependent immune effects in C57BL/6 mice

  2026cites this paper
• Immunotoxicity of Four Per- and Polyfluoroalkyl Substances Following 28-Day Oral Repeat Dosing in Rats Assessed by the Anti-Sheep Red Blood Cell IgM Response

  2025cites this paper
• Effects of perfluorooctanoic acid intraperitoneal exposures on neurobehavioral outcomes in C57Bl/6J mice

  2025cites this paper
• Potential role of vitamin C in mitigating perfluoroalkyl substances-induced immunotoxicity

  2025cites this paper
• Serum per- and polyfluoroalkyl substance (PFAS) levels and health-related biomarkers in a pilot study of skiers in New England.

  2024cites this paper
• Exploring Toxicity of Per- and Polyfluoroalkyl Substances (PFAS) Mixture Through ADMET and Toxicogenomic In Silico Analysis: Molecular Insights

  2024influential citation
• Associations between prenatal exposure to per- and polyfluoroalkyl substances and plasma immune molecules in three-year-old children in China.

  2024cites this paper
• Per- and polyfluoroalkyl substances alter innate immune function: evidence and data gaps

  2024cites this paper
• GenX analogs exposure induced greater hepatotoxicity than GenX mainly via activation of PPARα pathway while caused hepatomegaly in the absence of PPARα in female mice.

  2024cites this paper
• Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)

  2023cites this paper
• PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell lines

  2023cites this paper
• Weight of evidence evaluation for chemical-induced immunotoxicity for PFOA and PFOS: findings from an independent panel of experts

  2023influential citation
• A systematic evidence map of chronic inflammation and immunosuppression related to per- and polyfluoroalkyl substance (PFAS) exposure

  2022cites this paper
• Cross-sectional associations between serum PFASs and inflammatory biomarkers in a population exposed to AFFF-contaminated drinking water.

  2022cites this paper
• Immunotoxicity mechanisms of perfluorinated compounds PFOA and PFOS.

  2021cites this paper
• Critical evaluation of ToxCast-Reactome predicted toxicity pathway correspondence of the human liver HepG2 activity profile with observed PFOA and PFOS hazards

  2021cites this paper
• Perfluorooctanesulfonate and perfluorooctanoate exacerbate airway inflammation in asthmatic mice and in vitro.

  2020cites this paper
• [Effect of sublingual immunotherapy on inflammatory factors and autophagy in patients with allergic rhinitis].

  2020cites this paper
• Perfluorooctanoic acid activates the unfolded protein response in pancreatic acinar cells

  2020cites this paper
• The suppressive effect of dabrafenib, a therapeutic agent for metastatic melanoma, in IgE-mediated allergic inflammation.

  2020cites this paper
• Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances

  2020influential citation
• Hydro-ethanol extract of Holarrhena floribunda stem bark exhibits anti-anaphylactic and anti-oedematogenic effects in murine models of acute inflammation

  2020cites this paper
• Nothofagin suppresses mast cell-mediated allergic inflammation.

  2019cites this paper
• Correlation between mast cell-mediated allergic inflammation and length of perfluorinated compounds

  2018cites this paper
• Inhibitory Effect of Carnosol on Phthalic Anhydride-Induced Atopic Dermatitis via Inhibition of STAT3

  2017cites this paper
• Hydrated electron based decomposition of perfluorooctane sulfonate (PFOS) in the VUV/sulfite system.

  2017cites this paper